IMV Inc. (IMV) Shareholders Approve Reverse Stock Split at 88%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St futures drop as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Oil gains 3% as US-Iran peace talks in stalemate
- Oppenheimer sees AI software winners as focus shifts to ROI
- Trump says men arrested at UK air base used by US were looking to do 'big damage'
- Nvidia releases AI safety software it says could have stopped Hugging Face hack
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
IMV Shareholders Approve Reverse Stock Split at 88%
December 7, 2022 4:05 PM ESTIMVs common shares expected to begin trading on a split-adjusted basis on December 13, 2022
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- IMV Inc. (the Corporation) (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, announced today that at the special meeting of shareholders held on December 7, 2022, the share consolidation as described in the management information circular filed on October 28, 2022 (the Circular) was approved by the shareholders at 87.87% of the shares voted... More
